News
App Lets Amputees Program Their Own Bionic Hands
May 3, 2013 1:37 pm | by KATHY MATHESON - Associated Press | CommentsDouble-amputee Jason Koger used to fly hundreds of miles to visit a clinician when he wanted to adjust the grips on his bionic hands. Now, he's got an app. Koger came to Philadelphia this week to demonstrate the i-limb ultra revolution, a prosthetic developed by the British firm Touch Bionics....
Atrium Medical Announces 1-year results of the INFUSE-AMI Trial
May 3, 2013 1:00 pm | by PR Newswire | CommentsHUDSON, N.H., May 3, 2013 /PRNewswire/ -- Atrium Medical Corporation, a business unit of MAQUET Cardiovascular, today announced the 1-year results of the INFUSE-AMI (Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial. Dr. Gregg Stone, the...
EarlySense System Implementation Shown to Reduce Falls, Decrease Transfers to Hospitals and Increase the Quality of Care for Elderly in Multi-Center Nursing Home Study
May 3, 2013 1:00 pm | by PR Newswire | CommentsWALTHAM, Massachusetts, May 3, 2013 /PRNewswire/ -- EarlySense, the market leader in Proactive Patient Care Solutions™, announced today the results of a multi-center clinical study demonstrating that the EarlySense system helps medical teams at rehabilitation centers to reduce...
Researchers Determine Where Best to Place Defibrillators
May 3, 2013 9:55 am | by University of Toronto Faculty of Applied Science & Engineering | CommentsPrompt use of an automated external defibrillator, or AED, can greatly increase the survival rates of people who suffer a cardiac arrest. And MIE Professor Tim Chan, working with Dr. Laurie Morrison at St. Michael's Hospital, has developed a formula to determine where best to place these costly but life-saving devices.
Turning Human Stem Cells into Brain Cells Sheds Light on Neural Development
May 3, 2013 9:52 am | by Children's Hospital of Philadelphia | CommentsMedical researchers have manipulated human stem cells into producing types of brain cells known to play important roles in neurodevelopmental disorders such as epilepsy, schizophrenia and autism. The new model cell system allows neuroscientists to investigate normal brain development, as well as to identify specific disruptions in biological signals that may contribute to neuropsychiatric diseases.
St. Jude Medical Enrolls First Patient in Next-Generation Quadra Study
May 3, 2013 9:46 am | by Business Wire | CommentsSt. Jude Medical, a global medical device company, today announced first enrollment of its MultiPoint Pacing clinical study to build upon its first- to-market Quadripolar Pacing System. Patients will be implanted with the Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D) and Quartet lead to assess pacing in multiple locations in the heart.
BASi Launches Innovative Glucose Monitoring Project With Pinnacle Technology
May 3, 2013 9:41 am | by Business Wire | CommentsBASi has announced that it is collaborating with Pinnacle Technology Inc. in proof-of-concept studies combining BASi's Culex NxT automated blood sampling system with Pinnacle's glucose sensor to create an innovative new option for high quality data collection for diabetes and other glucose research.
Kips Bay Medical Announces the First eSVS Mesh Implant by the Mayo Clinic
May 3, 2013 9:37 am | by Business Wire | CommentsManny Villafaña, Chairman and CEO of Kips Bay Medical announced that on April 30, 2013, the Mayo Clinic performed its first implant of an eSVS Mesh at its Rochester, Minnesota facility. This implant was performed as part of the Kips Bay Medical eMESH I clinical feasibility trial currently being conducted for the U.S. FDA in a number of preeminent cardiac surgery centers in both Europe and the United States.
New Treatment Option for Patients in Ireland with Difficult to Treat Cancers
May 3, 2013 9:31 am | by Business Wire | CommentsToday, for the first time in Ireland, cancer patients can receive Novalis Radiosurgery treatment, with the opening of the Stereotactic Unit at St. Luke’s Radiation Oncology Centre at Beaumont Hospital. The technology, developed by Brainlab, offers new hope for cancer patients, many of whom have tumors that have been deemed inoperable.
Third Finger, Bionic Hand: Couple’s Joy As Wedding Ring Is Fitted To Ground-Breaking Hand
May 3, 2013 9:24 am | by RSLSteeper | CommentsLuke and Nancy Medland have expressed their joy after a special marital version of Luke’s bionic hand has been created – complete with a replica of his original wedding ring. Born without a left hand, Luke, 31, had used a variety of cosmetic hands with limited function for almost 20 years.
'Oil for the Joints' Offers Hope for Osteoarthritis Sufferers
May 3, 2013 9:23 am | by Michael Seele, Boston University College of Engineering | CommentsA team of researchers led by a Boston University Biomedical Engineer has developed a new joint lubricant that could bring longer lasting relief to millions of osteoarthritis sufferers. The new synthetic polymer supplements synovial fluid, the natural lubricant in joints, and works better than comparable treatments currently available.
iCAD’s Xoft Intraoperative Radiation Therapy System Featured at American Society of Breast Surgeons Conference
May 3, 2013 9:20 am | by The Associated Press | CommentsNASHUA, N.H. & CHICAGO--(BUSINESS WIRE)--May 3, 2013--Booth #303 -- iCAD, Inc. (Nasdaq: ICAD), a leading provider of advanced imaging and radiation therapy technologies for the detection and treatment of cancer, today announced that the Company’s Xoft ® Axxent ® Electronic Brachytherapy System...
Obesity Treatment Devices
May 3, 2013 12:00 am | by U.S. Food & Drug Administration | CommentsObesity is a major public health concern in the United States and has been linked to many health problems such as heart disease, stroke, diabetes, high blood pressure, sleep disorders, and breathing problems. Obesity (an excessive amount of body fat)...
Meeting Announcement: June 27, 2013 Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee
May 3, 2013 12:00 am | by U.S. Food & Drug Administration | CommentsOn June 27, 2013, during session I, the committee will discuss and make recommendations regarding the proposed classification of sorbent hemoperfusion systems, one of the remaining preamendments class III devices. The class III sorbent hemoperfusion system is a device intended for the treatment of poisoning, drug overdose, hepatic coma, and metabolic disturbances.
Robotic Angioplasty Achieves 97.6 Percent Clinical Success Rate
May 2, 2013 2:39 pm | by Business Wire | CommentsCorindus Vascular Robotics, a leading developer of precision vascular robotics, has announced that the Journal of American College of Cardiology published the results from its CorPath PRECISE study in the April 2013 issue. Results of the trial demonstrate the CorPath System is safe and feasible for patients, with significantly lower harmful radiation exposure to the operator.
